Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 5
2018 3
2019 12
2020 7
2021 6
2022 3
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases.
Fares J, Petrosyan E, Kanojia D, Dmello C, Cordero A, Duffy JT, Yeeravalli R, Sahani MH, Zhang P, Rashidi A, Arrieta VA, Ulasov I, Ahmed AU, Miska J, Balyasnikova IV, James CD, Sonabend AM, Heimberger AB, Lesniak MS. Fares J, et al. J Clin Invest. 2023 Dec 15;133(24):e161142. doi: 10.1172/JCI161142. J Clin Invest. 2023. PMID: 37847564 Free PMC article.
STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma.
Zhang P, Rashidi A, Zhao J, Silvers C, Wang H, Castro B, Ellingwood A, Han Y, Lopez-Rosas A, Zannikou M, Dmello C, Levine R, Xiao T, Cordero A, Sonabend AM, Balyasnikova IV, Lee-Chang C, Miska J, Lesniak MS. Zhang P, et al. Nat Commun. 2023 Mar 23;14(1):1610. doi: 10.1038/s41467-023-37328-9. Nat Commun. 2023. PMID: 36959214 Free PMC article.
B-cells Drive Response to PD-1 Blockade in Glioblastoma Upon Neutralization of TGFβ-mediated Immunosuppression.
Hou D, Castro B, Dapash M, Zolp A, Katz J, Arrieta V, Biermann J, Melms J, Kueckelhaus J, Benotmane J, Youngblood M, Rashidi A, Billingham L, Dmello C, Vazquez-Cervantes G, Lopez-Rosas A, Han Y, Patel R, Chia TY, Sun L, Prins R, Izar B, Heiland DH, Zhang P, Sonabend A, Miska J, Lesniak M, Zhao J, Lee-Chang C. Hou D, et al. Res Sq [Preprint]. 2023 Jan 9:rs.3.rs-2399170. doi: 10.21203/rs.3.rs-2399170/v1. Res Sq. 2023. PMID: 36711497 Free PMC article. Preprint.
Endoplasmic Reticulum Stress in the Brain Tumor Immune Microenvironment.
Petrosyan E, Fares J, Fernandez LG, Yeeravalli R, Dmello C, Duffy JT, Zhang P, Lee-Chang C, Miska J, Ahmed AU, Sonabend AM, Balyasnikova IV, Heimberger AB, Lesniak MS. Petrosyan E, et al. Mol Cancer Res. 2023 May 1;21(5):389-396. doi: 10.1158/1541-7786.MCR-22-0920. Mol Cancer Res. 2023. PMID: 36652630 Free PMC article.
Repurposing autophagy regulators in brain tumors.
Petrosyan E, Fares J, Cordero A, Rashidi A, Arrieta VA, Kanojia D, Lesniak MS. Petrosyan E, et al. Int J Cancer. 2022 Jul 15;151(2):167-180. doi: 10.1002/ijc.33965. Epub 2022 Mar 4. Int J Cancer. 2022. PMID: 35179776 Free PMC article. Review.
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer.
Cordero A, Ramsey MD, Kanojia D, Fares J, Petrosyan E, Schwartz CW, Burga R, Zhang P, Rashidi A, Castro B, Xiao T, Lee-Chang C, Miska J, Balyasnikova IV, Ahmed AU, Lesniak MS. Cordero A, et al. Proc Natl Acad Sci U S A. 2022 Jan 4;119(1):e2112491119. doi: 10.1073/pnas.2112491119. Proc Natl Acad Sci U S A. 2022. PMID: 34969858 Free PMC article.
38 results